| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. serves as a Chief Research Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $7.4M at current prices.
Historically, Rote William E.'s trades have earned a middling insider score of 58/100 across 20 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -15.7%.
The biggest single holding is TVTX (~$7.4M) as Chief Research Officer. The recent filings there lean toward selling, a net 164,628 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 825 | $16.59 | $13,686.75 | -1.4% | -4.8% | -59.5% | |
| Feb 1, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,590 | $22.25 | $57,627.50 | -4.1% | -29.2% | -61.1% | |
| Jan 24, 2023 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,062 | $21.50 | $44,333.00 | -4.6% | -2.9% | -58.3% | |
| May 11, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,563 | $21.71 | $33,940.25 | -1.7% | +30.5% | -24.4% | |
| Jan 31, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,125 | $27.40 | $30,825.00 | -2.4% | -6.4% | -18.5% | |
| Jan 24, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,875 | $24.98 | $46,837.50 | -4.9% | +9.9% | -16.2% | |
| Jan 11, 2022 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $27.40 | $68,500.00 | -6.1% | +3.2% | -25.6% | |
| Aug 17, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,407 | $17.12 | $24,085.45 | -3.8% | +48.9% | +40.8% | |
| May 12, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 3,125 | $19.30 | $60,312.34 | -4.6% | -27.7% | +10.6% | |
| Feb 18, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $28.01 | $70,025.00 | -3.4% | - | - |